International Business News - BMY http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Pharmaceuticals maker Bristol-Myers Squibb Co. has agreed to spend $3.65 million to resolve federal Clean Air Act violations by eliminating ozone-depleting refrigerants at factories in six states and Puerto Rico. http://www.ibtimes.com/articles/20080708/bristol-myers-agrees-to-upgrade-cooling-equipment.htm Tue, 08 Jul 2008 15:49:39 EDT Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs. http://www.ibtimes.com/articles/20080703/glaxosmithkline-to-appeal-81m-verdict-in-ala.htm Thu, 03 Jul 2008 18:26:03 EDT Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulations could mean longer, more costly clinical trials. http://www.ibtimes.com/articles/20080703/sector-snap-diabetes-drug-developers.htm Thu, 03 Jul 2008 11:34:53 EDT Shares of pharmaceutical companies were mostly higher early Thursday as the broader market wobbled following a Labor Department report showing the nation's unemployment rate held steady. http://www.ibtimes.com/articles/20080703/opening-glance-pharmaceutical-stocks-higher.htm Thu, 03 Jul 2008 10:00:37 EDT Shares of pharmaceutical companies closed mixed Wednesday as the broader market fell on another new record for oil. Light, sweet crude for August delivery rose as high as $144.32 on the New York Mercantile Exchange, but settled at $143.57, up $2.60 from the previous high from a day earlier. http://www.ibtimes.com/articles/20080702/closing-glance-pharmaceuticals-stocks-close-mixed.htm Wed, 02 Jul 2008 16:28:15 EDT Shares of pharmaceutical companies were mostly higher in early trading Wednesday as the broader market advanced ahead of a Commerce Department report on factory orders. http://www.ibtimes.com/articles/20080702/opening-glance-pharmaceutical-stocks-gain.htm Wed, 02 Jul 2008 09:49:47 EDT Shares of pharmaceutical companies rose Tuesday, as the broader market ended higher in an erratic session of ups and downs on rising oil prices and mixed auto sales numbers. http://www.ibtimes.com/articles/20080701/closing-glance-pharmaceuticals-rise.htm Tue, 01 Jul 2008 16:33:49 EDT Shares of pharmaceutical companies were mixed in early trading Tuesday as the broader market declined as investors worried about the impact of rising oil prices on consumer spending. http://www.ibtimes.com/articles/20080701/opening-glance-pharmaceuticals-mixed.htm Tue, 01 Jul 2008 10:10:04 EDT Shares of pharmaceutical companies opened mostly higher Monday, as the broader markets fluctuated amid another spike in oil prices. Monday is the last day of the second quarter, and institutional investors could be looking to make any changes that will put the best light on battered portfolios. http://www.ibtimes.com/articles/20080630/opening-glance-pharmaceuticals-rise.htm Mon, 30 Jun 2008 11:57:30 EDT Shares of pharmaceutical companies closed mostly higher Friday, while the broader market closed lower on an increase in oil prices and continued concerns about the financial sector. http://www.ibtimes.com/articles/20080627/closing-glance-pharmaceuticals.htm Fri, 27 Jun 2008 17:09:56 EDT Increasing efforts by U.S. cities such as New York to expand HIV testing will boost Gilead Sciences' bottomline, since more than 80 percent of the nation's newly diagnosed HIV patients begin treatment with either the company's Truvada or Atripla combination pills. http://www.ibtimes.com/articles/20080627/push-for-more-hiv-screens-to-drive-gileads-growth.htm Fri, 27 Jun 2008 16:00:49 EDT The Standard & Poor's 500 Index wobbled at midday Friday following the previous session's steep drop, as investors remained jittery over a fresh record in oil prices but got some relief from a Commerce Department report that personal spending rose. http://www.ibtimes.com/articles/20080627/midday-leaders-laggards-s-p-500.htm Fri, 27 Jun 2008 12:27:09 EDT Shares of OSI Pharmaceuticals Inc. rose Friday after a Thomas Weisel Partners analysts initiated coverage of the biopharmaceutical company with an "Overweight" rating, citing accelerating sales of the cancer drug Tarceva. http://www.ibtimes.com/articles/20080627/osi-shares-rise-on-weisel-overweight-rating.htm Fri, 27 Jun 2008 12:09:40 EDT Shares of pharmaceutical companies opened mostly higher Friday as the broader market shifted between gains and losses, as a new high in rise in oil prices was tempered by reports of increases in personal incomes and spending. http://www.ibtimes.com/articles/20080627/opening-glance-pharmaceuticals-mostly-higher.htm Fri, 27 Jun 2008 10:12:57 EDT Bristol-Myers Squibb completed its $234.6 million acquisition of Kosan Biosciences, the company said late Thursday. Excluding Kosan's cash balance, Bristol is paying about $190 million in cash for the company. Bristol previously said it is financing the deal with cash on hand. http://www.ibtimes.com/articles/20080627/bristol-myers-squibb-completes-kosan-acquisition.htm Fri, 27 Jun 2008 09:14:12 EDT Shares of pharmaceutical companies closed lower Thursday, with Pfizer hitting an 11-year low as the broader market fell sharply on a new record high in oil and fears of inflation. http://www.ibtimes.com/articles/20080626/closing-glance-pharmaceuticals.htm Thu, 26 Jun 2008 16:52:08 EDT Shares of pharmaceutical companies opened mostly lower Thursday as the broader market declined on a rise in oil prices and Goldman Sachs' downgrade of the brokerage sector. http://www.ibtimes.com/articles/20080626/opening-glance-pharmaceuticals.htm Thu, 26 Jun 2008 09:53:03 EDT Pharmaceutical stocks may have ended Wednesday's trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned that big pharma is no longer a strong defensive choice in a weak economy. http://www.ibtimes.com/articles/20080625/sector-wrap-big-pharma.htm Wed, 25 Jun 2008 16:47:05 EDT Shares of pharmaceutical companies opened mixed Wednesday as the broader market rose ahead of the Federal Reserve's decision on interest rates. In industry news, Merck said the Food and Drug Administration rejected an expanded indication for its cervical cancer vaccine Gardasil. http://www.ibtimes.com/articles/20080625/opening-glance-pharmaceuticals.htm Wed, 25 Jun 2008 10:19:30 EDT A JPMorgan analyst placed "Buy" ratings on shares of Merck & Co. and Schering-Plough Corp. Wednesday, but voiced cautions on the pharmaceutical sector and on shares of other major drug makers. http://www.ibtimes.com/articles/20080625/ahead-of-the-bell-major-pharmaceutical-companies.htm Wed, 25 Jun 2008 08:48:49 EDT